Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial
Blood Purification · 2023 · 52 (7-8) · 712-720
DOI: 10.1159/000531355 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Blood Purification, online erschienen am 20.07.2023. Verfasst von Olynka Vega-Vega und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Hemodiafiltration, Kidney Failure, Chronic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Introduction
Expanded hemodialysis (HDx) is expected to provide enhanced permeability of medium-sized molecules, selective solute retention, and better internal retrofiltration. The primary objective of this study was to compare the efficiency for removal of β2-microglobulin with 3 different extracorporeal therapies (ETs): high-flux hemodialysis (HF), online hemodiafiltration (OL-HDF), and HDx. The secondary objective was to evaluate the efficiency of removal of other uremic toxins, including urea, phosphate, CRP, IL-6, IL-10, TNF-⍺, indoxyl sulfate, and p-cresol.
Methods
This single-center, randomized, and cross-over study was performed. Patients were randomized to determine the initial modality of treatment, each period lasted 4 weeks and between one modality and another, there was a washout period of 1 week. Reduction ratios (RRs) of different-size molecules and albumin were calculated for the different ET.
Results
Twenty-two patients were included, β2-microglobulin RR was greater during both OL-HDF and HDx as compared to HF (RR 62% vs. 73% vs. 27%, respectively, p = <0.0001), and there was no significant difference between HDx and OL-HDF (p = 0.09). A decrease in serum phosphate levels was observed in the HDx and OL-HDF periods, contrary to an increase in HF (−0.79 mg/dL vs. −1.02 mg/dL vs. + 0.11 mg/dL, respectively, p = <0.0001). There was no difference in RRs of other molecules (BUN, CRP, IL-6, IL-10, TNF-⍺, indoxyl sulfate, and p-Cresol). There was no decrease in serum albumin in any ET.
Conclusion
HDx provides enhanced removal of β2-microglobulin and phosphate as compared to HF, and similar efficacy as with OL-HDF. HDx should be considered an alternative to chronic convective therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, adrian.caballero24@gmail.com.
- Postgraduate Division, Faculty of Superior Studies of Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Zitieren
APA
Vega-Vega, O., Caballero-Islas, A. E., Del Toro-Cisneros, N., Hernandez-Ordoñez, S. Ó., Arvizu-Hernández, M., Martínez-Rueda, A., Camacho-Colin, D., Gómez-Correa, L. L., & Correa-Rotter, R. (2023). Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial. Blood Purification, 52(7-8), 712-720. https://doi.org/10.1159/000531355
Vancouver
Vega-Vega O, Caballero-Islas AE, Del Toro-Cisneros N, Hernandez-Ordoñez SÓ, Arvizu-Hernández M, Martínez-Rueda A, et al. Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial. Blood Purification. 2023;52(7-8):712-720. doi:10.1159/000531355
BibTeX
@article{VegaVega2023,
author = {Vega-Vega, Olynka and Caballero-Islas, Adrián E and Del Toro-Cisneros, Noemí and Hernandez-Ordoñez, Sergio Óscar and Arvizu-Hernández, Mauricio and Martínez-Rueda, Armando and Camacho-Colin, Diana and Gómez-Correa, Leidi Laura and Correa-Rotter, Ricardo},
title = {Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial},
journal = {Blood Purification},
year = {2023},
volume = {52},
number = {7-8},
pages = {712--720},
doi = {10.1159/000531355}
}
EUVIMED